Skip to main content
Fig. 2 | Journal of Translational Medicine

Fig. 2

From: Circulating DNA as prognostic biomarker in patients with advanced hepatocellular carcinoma: a translational exploratory study from the SORAMIC trial

Fig. 2

Schematic description of the experimental workflow. Peripheral blood was collected and processed to separate plasma from buffy coat containing white blood cells (WBC). Whole circulating DNA was extracted and used for library preparation. Next generation sequencing was performed on Illumina platform using the 150 paired-end (PE) mode. To distinguish somatic from germline mutations, genomic DNA extracted from WBC was analyzed in parallel

Back to article page